ESCAZYME BIOCHEMICALS, LLC

Biotech · Private

Enzymatically synthesized lutein and zeaxanthin using recombinant enzymes and enantiomerically-enriched ipsdienol precursors

Grants
$122K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Biocatalytic production of precursors to lutein and zeaxanthin to address age-related macular degeneration$121,978
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3107MICROPURE GENOMICS INC——
3108ERNEST PHARMACEUTICALS LLC——
3109MECHASIM INC.——
3110ESCAZYME BIOCHEMICALS, LLC——
3111SUR180 THERAPEUTICS, INC.——
3112Cybrexa, Inc.——
3113GENERAL BIOLOGICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.